ClinVar Miner

Submissions for variant NM_000237.3(LPL):c.106G>A (p.Asp36Asn)

gnomAD frequency: 0.01951  dbSNP: rs1801177
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000352575 SCV000472748 benign Hyperlipoproteinemia, type I 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000454647 SCV000539547 likely benign not specified 2016-03-28 criteria provided, single submitter clinical testing Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC frequency, association with hyperlipidemia.
Eurofins Ntd Llc (ga) RCV000733476 SCV000861552 other not provided 2018-06-13 criteria provided, single submitter clinical testing
Mendelics RCV000352575 SCV001137594 benign Hyperlipoproteinemia, type I 2019-05-28 criteria provided, single submitter clinical testing
Invitae RCV000733476 SCV001731106 benign not provided 2024-01-31 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000352575 SCV001737362 benign Hyperlipoproteinemia, type I 2021-06-10 criteria provided, single submitter clinical testing
GeneDx RCV000733476 SCV001843677 benign not provided 2019-10-22 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 11260209, 8839720, 15049943, 9678774, 28267856, 8872057, 10517255, 8541837, 8199176, 7749858, 26934567, 27055971, 24503134, 24123366, 21146168, 18823627, 12535736, 18922999, 28008009, 10364086)
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000454647 SCV002050870 likely benign not specified 2021-12-10 criteria provided, single submitter clinical testing
Ambry Genetics RCV002408446 SCV002720847 benign Cardiovascular phenotype 2019-03-21 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
PreventionGenetics, part of Exact Sciences RCV003924794 SCV004743366 benign LPL-related disorder 2019-09-25 criteria provided, single submitter clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
OMIM RCV000001617 SCV000021773 risk factor Hyperlipidemia, familial combined, susceptibility to 1999-08-01 no assertion criteria provided literature only
Blueprint Genetics RCV000157298 SCV000207030 risk factor Coronary heart disease 2014-09-15 no assertion criteria provided clinical testing
Natera, Inc. RCV000352575 SCV001454747 benign Hyperlipoproteinemia, type I 2020-01-02 no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000733476 SCV001970444 pathogenic not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.